Quantcast
Swissmedic approves J&J COVID-19 vaccine booster – Metro US

Swissmedic approves J&J COVID-19 vaccine booster

FILE PHOTO: Johnson & Johnson COVID-19 vaccine is administered in
FILE PHOTO: Johnson & Johnson COVID-19 vaccine is administered in Bay Shore, NY

ZURICH (Reuters) – Swiss drugs regulator Swissmedic said on Monday it approved booster doses for Johnson & Johnson’s COVID-19 vaccine in people 18 years and older who have received a first vaccination.

The second dose of the vaccine can be administered, at the earliest, two months after the first dose, Swissmedic said in a statement.

It said mixed vaccinations with the J&J shot being administered six months after the second dose of Pfizer/BioNTech’s or Moderna’s mRNA vaccines were also authorised.

(Reporting by Silke Koltrowitz, Editing by Miranda Murray)

More from our Sister Sites